BG
Bellevue Group’s Exact Sciences EXAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.1M | Sell |
284,201
-294,873
| -51% | -$15.7M | 0.33% | 54 |
|
|
2025
Q1 | $25.1M | Sell |
579,074
-114,982
| -17% | -$4.98M | 0.56% | 42 |
|
|
2024
Q4 | $39M | Sell |
694,056
-755,409
| -52% | -$42.4M | 0.75% | 28 |
|
|
2024
Q3 | $98.7M | Buy |
1,449,465
+290,585
| +25% | +$19.8M | 1.6% | 18 |
|
|
2024
Q2 | $49M | Buy |
1,158,880
+20,354
| +2% | +$860K | 0.8% | 29 |
|
|
2024
Q1 | $78.6M | Buy |
1,138,526
+90,740
| +9% | +$6.27M | 1.2% | 23 |
|
|
2023
Q4 | $77.5M | Sell |
1,047,786
-72,033
| -6% | -$5.33M | 1.19% | 24 |
|
|
2023
Q3 | $76.4M | Buy |
1,119,819
+113,047
| +11% | +$7.71M | 1.23% | 21 |
|
|
2023
Q2 | $94.5M | Sell |
1,006,772
-218,270
| -18% | -$20.5M | 1.35% | 24 |
|
|
2023
Q1 | $83.1M | Sell |
1,225,042
-86,973
| -7% | -$5.9M | 1.21% | 27 |
|
|
2022
Q4 | $65M | Buy |
1,312,015
+182,362
| +16% | +$9.03M | 0.86% | 35 |
|
|
2022
Q3 | $36.7M | Buy |
1,129,653
+371,630
| +49% | +$12.1M | 0.53% | 56 |
|
|
2022
Q2 | $29.9M | Buy |
758,023
+38,720
| +5% | +$1.53M | 0.42% | 65 |
|
|
2022
Q1 | $50.3M | Buy |
719,303
+76,721
| +12% | +$5.36M | 0.58% | 57 |
|
|
2021
Q4 | $50M | Buy |
642,582
+213,309
| +50% | +$16.6M | 0.52% | 65 |
|
|
2021
Q3 | $41M | Buy |
429,273
+153,600
| +56% | +$14.7M | 0.42% | 76 |
|
|
2021
Q2 | $34.3M | Buy |
275,673
+57,533
| +26% | +$7.15M | 0.33% | 88 |
|
|
2021
Q1 | $28.7M | Buy |
218,140
+23,140
| +12% | +$3.05M | 0.3% | 91 |
|
|
2020
Q4 | $25.8M | Sell |
195,000
-109,490
| -36% | -$14.5M | 0.3% | 86 |
|
|
2020
Q3 | $31M | Buy |
+304,490
| New | +$31M | 0.43% | 63 |
|